TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

Image: TaiwanJ Pharmaceuticals obtained $26m deal for licensing and co-development contract with Newsoara Biopharma on JKB-122 Asian rights. Photo: courtesy of rawpixel/Unsplash.com.